top of page

What we do
TheraLyze.ai revolutionizes case intake by eliminating manual data entry and significantly reducing the total time spent on processing and submitting cases to regulators.
Use Case
CROs and pharmaceutical companies use TheraLyze.ai to automate case intake, extract key data, generate E2B R3 files, and integrate seamlessly with pharmacovigilance databases.
How it works
Users upload raw safety data to TheraLyze.ai, which processes the files using AI, extracts relevant information, and generates structured E2B R3 files ready for submission to any PV Database for regulatory authorities.


Founder, CEO
Sunil Kulkarni, founder & CEO of TheraLyze.ai, leverages deep expertise in technology and life sciences. Formerly a leader at Veeva Systems, he specializes in AI, machine learning, and scalable tools & solutions to save time, streamline workflows, boost quality, and ensure compliance.

(Head of Global Pharmacovigilance, Worwag Pharma)
bottom of page